Clinical considerations in developing dendritic cell vaccine based immunotherapy protocols in cancer

Current Molecular Medicine

Volumn 9, Issue 6, 2009, Pages 725-731

  Murthy, Vedang ^a   Moiyadi, Aliasgar ^a   Sawant, Rajesh ^a   Sarin, Rajiv ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cancer immunotherapy; Clinical trial design; Dendritic cell vaccine; Vaccine protocol

Indexed keywords

CANCER VACCINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DENDRITIC CELL VACCINE;

ADVANCED CANCER; AGE; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; EXPERIMENTAL THERAPY; FATIGUE; FEVER; FLU LIKE SYNDROME; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; INJECTION SITE REACTION; KIDNEY CANCER; KIDNEY FUNCTION; LEUKAPHERESIS; LIFE EXPECTANCY; LIVER FUNCTION; LOW DRUG DOSE; LYMPHOMA; MAXIMUM TOLERATED DOSE; MELANOMA; METASTASIS; METHODOLOGY; MONOCYTE; MYALGIA; MYELOMA; NAUSEA AND VOMITING; NONHUMAN; PAIN; PREGNANT WOMAN; RASH; REVIEW; SEX DIFFERENCE; TOXICITY TESTING; TUMOR GROWTH; TUMOR VOLUME; VITILIGO;

ANIMALS; CANCER VACCINES; DENDRITIC CELLS; ENDPOINT DETERMINATION; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

DROSOPHILA C VIRUS;

EID: 70350532950     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652409788970689     Document Type: Review

References (37)

1. Prestwich, R.J., Errington, F., Hatfield, P., Merrick, A.E., Ilett, E.J., Selby, P.J. and Melcher, A.A. (2008) Clin. Oncol. (R Coll Radiol), 20, 101-112.
2. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. and Levy, R. (1996) Nat. Med., 2, 52-58.
3. Murphy, G., Tjoa, B., Ragde, H., Kenny, G. and Boynton, A. (1996) Prostate, 29, 371-380.
4. Ridgway, D. (2003) Cancer Invest., 21, 873-886.
5. Zhong, H., Shurin, M.R. and Han, B. (2007) Expert Rev. Vaccines, 6, 333-345.
6. Hoos, A., Parmiani, G., Hege, K., Sznol, M., Loibner, H., Eggermont, A., Urba, W., Blumenstein, B., Sacks, N., Keilholz, U. and Nichol, G. (2007) J. Immunother., 30, 1-15.
7. Figdor, C.G., de Vries, I.J., Lesterhuis, W.J. and Melief, C.J. (2004) Nat. Med., 10, 475-480.
8. Reichardt, V.L., Brossart, P. and Kanz, L. (2004) Blood Rev., 18, 235-243.
9. Shurin, M.R., Shurin, G.V. and Chatta, G.S. (2007) Crit. Rev. Oncol. Hematol., 64, 90-105.
10. Gravekamp, C. (2007) Exp. Gerontol., 42, 441-450.
11. Upham, J.W., Rate, A., Rowe, J., Kusel, M., Sly, P.D. and Holt, P.G. (2006) Infect. Immun., 74, 1106-1112.
12. Geiger, J.D., Hutchinson, R.J., Hohenkirk, L.F., McKenna, E.A., Yanik, G.A., Levine, J.E., Chang, A.E., Braun, T.M. and Mule, J.J. (2001) Cancer Res., 61, 8513-8519.
13. Merrill, R.M., Isakson, R.T. and Beck, R.E. (2007) Ann Allergy Asthma Immunol., 99, 102-116; quiz 117-109, 150.
14. Bondanza, A., Zimmermann, V.S., Dell'Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M.G., Manfredi, A.A. and Rovere-Querini, P. (2003) J. Immunol., 170, 24-27.
15. Cardonick, E. and Iacobucci, A. (2004) Lancet Oncol., 5, 283-291.
16. Kal, H.B. and Struikmans, H. (2005) Lancet Oncol., 6, 328-333.
17. Mir, O., Berveiller, P., Ropert, S., Goffinet, F., Pons, G., Treluyer, J.M. and Goldwasser, F. (2008) Ann Oncol., 19, 607-613.
18. Bachy, V., Williams, D.J. and Ibrahim, M.A. (2008) J. Reprod. Immunol., 78, 11-21.
19. Nagorsen, D. and Thiel, E. (2008) Cancer Immunol. Immunother., 57(12), 1903-1910.
20. McDermott, D.F. and Rini, B.I. (2007) BJU Int., 99, 1282-1288.
21. Sondak, V.K. and Sosman, J.A. (2003) Semin Cancer Biol., 13, 409-415.
22. Jocham, D., Richter, A., Hoffmann, L., Iwig, K., Fahlenkamp, D., Zakrzewski, G., Schmitt, E., Dannenberg, T., Lehmacher, W., von Wietersheim, J. and Doehn, C. (2004) Lancet, 363, 594-599.
23. Serody, J.S., Collins, E.J., Tisch, R.M., Kuhns, J.J. and Frelinger, J.A. (2000) J. Immunol., 164, 4961-4967.
24. Adema, G.J., de Vries, I.J., Punt, C.J. and Figdor, C.G. (2005) Curr. Opin. Immunol., 17, 170-174.
25. Lesterhuis, W.J., Aarntzen, E.H., De Vries, I.J., Schuurhuis, D.H., Figdor, C.G., Adema, G.J. and Punt, C.J. (2008) Crit. Rev. Oncol. Hematol., 66, 118-134.
26. Nestle, F.O., Farkas, A. and Conrad, C. (2005) Curr. Opin. Immunol., 17, 163-169.
27. Mullins, D.W., Sheasley, S.L., Ream, R.M., Bullock, T.N., Fu, Y.X. and Engelhard, V.H. (2003) J. Exp. Med., 198, 1023-1034.
28. Loftus, T.J., White, R.F. and Huestis, D.W. (1983) J. Clin. Apher., 1, 109-114.
29. Chakraborty, M., Abrams, S.I., Camphausen, K., Liu, K., Scott, T., Coleman, C.N. and Hodge, J.W. (2003) J. Immunol., 170, 6338-6347.
30. Demaria, S., Bhardwaj, N., McBride, W.H. and Formenti, S.C. (2005) Int. J. Radiat. Oncol. Biol. Phys., 63, 655-666.
31. Chen, Z., Xia, D., Bi, X., Saxena, A., Sidhu, N., El-Gayed, A. and Xiang, J. (2005) J. Gene Med., 7, 506-517.
32. Liu, J.Y., Wu, Y., Zhang, X.S., Yang, J.L., Li, H.L., Mao, Y.Q., Wang, Y., Cheng, X., Li, Y.Q., Xia, J.C., Masucci, M. and Zeng, Y.X. (2007) Cancer Immunol. Immunother., 56, 1597-1604.
33. Zhong, H., Han, B., Tourkova, I.L., Lokshin, A., Rosenbloom, A., Shurin, M.R. and Shurin, G.V. (2007) Clin. Cancer Res., 13, 5455-5462.
34. Cerundolo, V., Hermans, I.F. and Salio, M. (2004) Nat. Immunol., 5, 7-10.
35. Banchereau, J., Palucka, A.K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K.M., Bhardwaj, N., Pineiro, L., Steinman, R. and Fay, J. (2001) Cancer Res., 61, 6451-6458.
36. Hersey, P., Menzies, S.W., Halliday, G.M., Nguyen, T., Farrelly, M.L., DeSilva, C. and Lett, M. (2004) Cancer Immunol. Immunother., 53, 125-134.
37. Gilboa, E. (2001) Nat. Immunol., 2, 789-792.